Glial Fibrillary Acidic Protein in the Diagnosis and Prognosis of Malignant Glial Tumors

Pre- and early postoperative GFAP serum levels in glioma and brain metastases

(2018) Peter Baumgarten et al.   JOURNAL OF NEURO-ONCOLOGY

Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury

(2016) Riikka S.K. Takala et al.   World Neurosurgery

Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival

(2015) Aida Kiviniemi et al.   JOURNAL OF NEURO-ONCOLOGY

Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma

(2015) Julia Tichy et al.   JOURNAL OF NEURO-ONCOLOGY

Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma

(2014) Jaime Gállego Pérez-Larraya et al.   CANCER

Role of microRNAs in mechanisms of glioblastoma resistance to radio- and chemotherapy

(2013) Ph. A. Koshkin et al.   BIOCHEMISTRY-MOSCOW

Neurospecific Proteins in the Serum of Patients with Brain Tumors

(2011) N. V. Lyubimova et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Diagnostic Accuracy of Plasma Glial Fibrillary Acidic Protein for Differentiating Intracerebral Hemorrhage and Cerebral Ischemia in Patients with Symptoms of Acute Stroke

(2011) C. Foerch et al.   CLINICAL CHEMISTRY